Anika Therapeutics, Inc. (ANIK) operating margin

Operating margin · fiscal 2025
-9.8%

Anika Therapeutics, Inc. (ANIK) had an operating margin of -9.8% in fiscal 2025 (the year ended December 31, 2025). That is 5.5 percentage points lower than the -4.3% of fiscal 2024. Figures as of 19 Nov 2026, 13:08 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Operating margin, fiscal 2025
-9.8%
Change on fiscal 2024
−5.5 pts
Highest on record
58.2%fiscal 2014
Lowest on record
-21.7%fiscal 2020
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Anika Therapeutics, Inc. operating margin, in more detail

Across the 17 fiscal years on record (2009–2025), the highest was 58.2% in fiscal 2014 and the lowest -21.7% in fiscal 2020. The fiscal 2025 figure is higher than in 6% of the 16 earlier fiscal years on record, whose median is 21.1%.

Gross margin was 56.6% in fiscal 2025. Net margin was -9.6% in fiscal 2025.

History · 17 fiscal years

Operating margin by fiscal year

  • Operating margin
  • Gross margin
  • Net margin

Anika Therapeutics, Inc. operating margin, year by year

Anika Therapeutics, Inc. (ANIK) operating margin by fiscal year
Fiscal yearOperating marginChangeYear endedGross marginNet margin
2025-9.8% 5.5 pts down56.6%-9.6%
2024-4.3% 5.0 pts down63.4%-47.0%
20230.7% 2.5 pts down68.3%-68.4%
20223.2% 1.5 pts up64.3%-13.1%
20211.8% 23.5 pts up56.1%2.8%
2020-21.7% 51.6 pts down52.9%-18.4%
201929.9% 9.3 pts up74.9%23.7%
201820.6% 19.7 pts down70.4%17.7%
201740.3% 8.6 pts down—28.1%
201649.0% 2.8 pts down—31.5%
201551.8% 6.4 pts down—33.1%
201458.2% 14.8 pts up—36.3%
201343.4% 15.8 pts up—27.4%
201227.6% 6.1 pts up—16.5%
201121.6% 8.0 pts up—13.1%
201013.6% 0.4 pts down—7.8%
200913.9%——9.2%

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

How to read it

It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.

More on ANIK

Anika Therapeutics, Inc., figure by figure

Anika Therapeutics, Inc. (ANIK) overview: price, valuation and scorecard

Anika Therapeutics, Inc. operating margin: questions and answers

What is Anika Therapeutics, Inc.'s operating margin?

Anika Therapeutics, Inc. (ANIK) had an operating margin of -9.8% in fiscal 2025 (the year ended December 31, 2025). That is 5.5 percentage points lower than the -4.3% of fiscal 2024.

Is Anika Therapeutics, Inc.'s operating margin high or low compared with its own history?

The fiscal 2025 figure is higher than in 6% of the 16 earlier fiscal years on record, whose median is 21.1%.

What are the highest and lowest operating margin figures on record for Anika Therapeutics, Inc.?

Across the 17 fiscal years on record (2009–2025), the highest was 58.2% in fiscal 2014 and the lowest -21.7% in fiscal 2020.

What are Anika Therapeutics, Inc.'s gross and net margins?

Gross margin was 56.6% in fiscal 2025. Net margin was -9.6% in fiscal 2025.

How is Anika Therapeutics, Inc.'s operating margin calculated?

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income. For Anika Therapeutics, Inc. it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Anika Therapeutics, Inc. (ANIK) operating margin”, data as of 19 November 2026. https://funkfolio.com/stock/ANIK/operating-margin

Underlying data: the company's filings with the SEC and Yahoo Finance.